Reclassification of preamendments devices
This article was originally published in The Gray Sheet
Executive Summary
Final rule issued March 31 withholds action on 10 of the 38 preamendments devices previously proposed for reclassification from Class III to Class II, including pacemaker lead adapters, annuloplasty rings and vascular graft prostheses less than 6 mm in diameter (1"The Gray Sheet" March 22, 1999, p. 10). The agency announced the postponement of action for six of the devices in June due to the lack of existing guidance to serve as special controls. Rule finalizes downclassification of remaining 28 devices, all of which are addressed by FDA guidance
You may also be interested in...
FDA Issues First Mass Downclassification Of Preamendments Class III Devices
FDA's reclassification of 38 preamendments devices from Class III into Class II cuts to less than 30 the number of pre-1976 Class III devices on which the Center for Devices and Radiological Health has not initiated some regulatory action.
Incyte Hopes To Augment Immune/Inflammation Pipeline With Escient Deal
Incyte will pay $750m to acquire privately held Escient and its first-in-class oral antagonists of Mas-related G protein-coupled receptors X2 and X4.
Sanofi Clinches Key Phase III Immunology Win With Rilzabrutinib
Sanofi’s BTK inhibitor – one of two from its 2021 Principia buy – passed a Phase III test in immune thrombocytopenia as the company focuses on Dupixent-like blockbusters going forward.